Publications

Loftus, B., B. Newsom, M. Montgomery, K. Von Gynz-Rekowski, M. Riser, S. Inman, P. Garces, D. Rill, J. Zhang, J.Williams. (2009) Autologous attenuated T-Cell vaccine (Tovaxin®) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies. Clinical Immunology.131:202-215. Zhang, J. (2001) T cell vaccination in multiple sclerosis: Prospects for therapy. Crit Rev Immunol. 21(1-3):41-55.M

Zang, Y., J. Hong, S. Li, J. M. Killian, V. M. Rivera, J. Zhang. (2000) Preferential recognition of hypervariable region sequence by I anti-idiotypic T cells induced by T cell vaccination in patients with multiple sclerosis. J Immunol. 164:4011.

Hong, J., Zang, Y., Rivera, V., and Zhang. J. (2000) Reactivity and regulatory properties of anti-idiotypic antibodies induced by T cell vaccination in patients with multiple sclerosis. J Immunol. 165:6858.

Zang, Y., Kozovska, M., Li, S., Killian, J., Rivera, V., and Zhang, J. (2000) Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol. 30:908.

Zhang, J., P. Stinissen, R. Medaer and J. Raus. (1998) T cell vaccination: new treatment for multiple sclerosis. In Immunotherapy in Neuroimmunologic Diseases. Jingwu Zhang, et al. (eds.), Martin Dunitz Publishers, London, pp 215-232.

Zhang, J., P. Stinissen, R. Medaer and J. Raus. (1996) T cell vaccination: clinical applications in autoimmune disease. Journals of Molecular Medicine 74:653.